Stockreport

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

23andMe Holding Co.  (ME) 
PDF Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alt [Read more]